Diatrizoate Sodium/Meglumine diatrizoate

泛影酸钠/泛影葡胺

Report date: 2025/07/16 17:31:59

Base Information

Drug NameDiatrizoate Sodium/Meglumine diatrizoate
Drug Alias Name复方泛影葡胺注射液Gastrografin
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsContrast agentsIntestinal Obstruction
Global Approved IndicationsContrast agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes Diatrizoate SodiumMeglumine diatrizoate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesLiebel-Flarsheim Company Llc
Active IndicationsContrast agentsIntestinal Obstruction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A